Understanding the Current Rating
The Strong Sell rating assigned to Deep Health AI India Ltd indicates a cautious stance for investors, signalling that the stock is expected to underperform relative to the broader market and its peers. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential as of today.
Quality Assessment
As of 27 May 2026, Deep Health AI India Ltd’s quality grade is classified as below average. The company’s long-term fundamental strength remains weak, with an average Return on Equity (ROE) of 7.89%. This level of ROE suggests limited efficiency in generating profits from shareholders’ equity compared to industry standards. Additionally, the company’s ability to service its debt is concerning, with an average EBIT to Interest ratio of just 1.26, indicating tight coverage of interest expenses and potential financial strain.
Valuation Perspective
The valuation grade for Deep Health AI India Ltd is currently expensive. Despite trading at a Price to Book (P/B) ratio of 1.3, which is somewhat discounted relative to its peers’ historical averages, the stock’s valuation remains elevated given its fundamentals. The company’s ROE of 11.6% contrasts with its high valuation, suggesting that investors may be paying a premium for growth expectations. Notably, the stock offers a dividend yield of 4.3%, which is attractive in the current market environment, but this yield must be weighed against the risks implied by other financial metrics.
Financial Trend and Profitability
Financially, the company shows a positive trend. The latest data as of 27 May 2026 reveals a remarkable 589% increase in profits over the past year, a significant turnaround that contrasts with the stock’s negative price performance. Despite this profit surge, the stock has delivered a 1-year return of -49.72%, reflecting a disconnect between market sentiment and underlying earnings growth. The PEG ratio stands at zero, indicating that the price-to-earnings growth relationship is currently unfavourable or not meaningful due to the recent profit volatility.
Technical Analysis
From a technical standpoint, Deep Health AI India Ltd is rated bearish. The stock’s price action over recent months has been weak, with a 6-month decline of 72.20% and a year-to-date loss of 60.37%. Short-term movements show some recovery, with a 1-day gain of 1.3% and a 1-week increase of 5.43%, but these are insufficient to offset the broader downtrend. The technical grade reflects persistent selling pressure and a lack of sustained momentum, signalling caution for traders and investors alike.
Performance Relative to Benchmarks
Deep Health AI India Ltd has consistently underperformed the BSE500 benchmark over the last three years. The stock’s negative returns over the past year and beyond highlight ongoing challenges in regaining investor confidence. This underperformance, combined with the company’s fundamental and technical weaknesses, supports the current Strong Sell rating.
Implications for Investors
For investors, the Strong Sell rating suggests that Deep Health AI India Ltd is currently a high-risk holding with limited upside potential. The combination of weak quality metrics, expensive valuation, bearish technical signals, and inconsistent financial trends advises prudence. Investors should carefully consider these factors in the context of their portfolios and risk tolerance before initiating or maintaining positions in this stock.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
Summary of Key Metrics as of 27 May 2026
Deep Health AI India Ltd’s microcap status within the Gems, Jewellery And Watches sector places it in a niche market segment. The Mojo Score currently stands at 23.0, reflecting the Strong Sell grade, down from 33 previously. The stock’s recent price volatility is evident in its returns: a 1-day gain of 1.3%, a 1-week rise of 5.43%, but declines of 5.67% over 1 month, 20.48% over 3 months, and a steep 72.20% over 6 months. Year-to-date and 1-year returns remain deeply negative at -60.37% and -49.72%, respectively.
The company’s financial health is mixed. While profit growth has been impressive, the underlying fundamentals and technical outlook remain weak. The valuation premium and poor debt servicing capacity further complicate the investment case.
What This Means Going Forward
Investors should approach Deep Health AI India Ltd with caution. The Strong Sell rating reflects a consensus view that the stock is likely to face continued headwinds. Monitoring future earnings reports, debt management, and technical signals will be crucial for reassessing the stock’s outlook. For those seeking exposure to the sector, alternative companies with stronger fundamentals and more favourable valuations may offer better risk-adjusted returns.
In conclusion, the current Strong Sell rating by MarketsMOJO, last updated on 11 Feb 2026, is supported by a thorough analysis of the company’s quality, valuation, financial trends, and technical position as of 27 May 2026. This comprehensive view provides investors with a clear understanding of the risks and challenges associated with Deep Health AI India Ltd at this time.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
